Success Stories & Lessons Learned: TAVNEOS (Avacopan) – an Oral Inhibitor of the Complement C5a Receptor for the Treatment of ANCAAssociated Vasculitis

Time: 9:00 am
day: Day Two

Details:

  • Providing a disease and biology overview
  • Sharing experiences from non-clinical and clinical development
  • Addressing lessons learned from the journey

Speakers: